Literature DB >> 23750799

Rapid loss of efficacy to the antiseizure drugs lamotrigine and carbamazepine: a novel experimental model of pharmacoresistant epilepsy.

Ajay K Srivastava1, Anitha B Alex, Karen S Wilcox, H Steve White.   

Abstract

PURPOSE: Kindling is a well-established model of secondarily generalized partial seizures that is widely employed in the search for novel antiseizure drugs. During the kindling and postkindling acquisition phase, an active process of neuronal remodeling occurs. We tested the hypothesis that exposure to the voltage-gated sodium channel blockers lamotrigine (LTG) and carbamazepine (CBZ) during the period of active remodeling will lead to a diminished therapeutic effect.
METHODS: Two days after the last kindling stimulation, fully kindled rats were randomized to receive either 0.5% methyl cellulose (MC), LTG (30 mg/kg), or CBZ (40 mg/kg). The effect of LTG and CBZ on behavioral seizure severity and electrographic afterdischarge duration (ADD) was recorded. One week after this treatment, rats in both groups were rechallenged with LTG 30 or CBZ 40 mg/kg and their seizure score and ADD recorded. In vitro efficacy of LTG on neuronal action potentials was also evaluated using whole cell current clamp recording in hippocampal brain slices obtained from kindled control rats, LTG-sensitive kindled rats, and LTG-resistant kindled rats. KEY
FINDINGS: When acutely administered 48 h after the last kindling stimulation, LTG and CBZ blocked the expression of behavioral seizures and reduced the ADD. In contrast, a second challenge dose of LTG or CBZ administered after a 7-day "no drug, no stimulation" period did not result in reduction of either the seizure score or the ADD. Interestingly, the potassium channel opener, ezogabine, also known as retigabine (EZG; 40 mg/kg), blocked the expression of behavioral seizures at both time points evaluated (i.e., 2 days and 9 days after last stimulation). In vivo resistance to LTG was associated with a similar reduction in the ability of LTG to limit action potential firing in CA1 neurons. LTG (50 μm) significantly decreased the number of action potentials generated by a depolarizing current pulse in neurons recorded from slices obtained from kindled control and LTG-sensitive rats, but not in slices obtained from LTG-resistant rats. SIGNIFICANCE: Collectively, results obtained from both in vivo and in vitro studies demonstrate that even a single exposure to the sodium channel blockers LTG, or CBZ, during the postkindling remodeling phase leads to an altered pharmacologic response to these two ASDs, but not to EZG. The LTG- and CBZ-resistant amygdala kindled rats may serve as a useful model of therapy-resistant epilepsy. Wiley Periodicals, Inc.
© 2013 International League Against Epilepsy.

Entities:  

Keywords:  Carbamazepine; Kindling; Lamotrigine; Pharmacoresistance; Seizure animal model

Mesh:

Substances:

Year:  2013        PMID: 23750799      PMCID: PMC3735163          DOI: 10.1111/epi.12234

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  29 in total

1.  Changes in the mRNAs encoding voltage-gated sodium channel types II and III in human epileptic hippocampus.

Authors:  W R Whitaker; R L Faull; M Dragunow; E W Mee; P C Emson; J J Clare
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

2.  Modulation of sodium currents in rat CA1 neurons by carbamazepine and valproate after kindling epileptogenesis.

Authors:  M Vreugdenhil; W J Wadman
Journal:  Epilepsia       Date:  1999-11       Impact factor: 5.864

3.  Lamotrigine treatment during amygdala-kindled seizure development fails to inhibit seizures and diminishes subsequent anticonvulsant efficacy.

Authors:  T Postma; E Krupp; X L Li; R M Post; S R Weiss
Journal:  Epilepsia       Date:  2000-12       Impact factor: 5.864

4.  A novel mechanism underlying drug resistance in chronic epilepsy.

Authors:  Stefan Remy; Siegrun Gabriel; Bernd W Urban; Dirk Dietrich; Thomas N Lehmann; Christian E Elger; Uwe Heinemann; Heinz Beck
Journal:  Ann Neurol       Date:  2003-04       Impact factor: 10.422

5.  Induction of neonatal sodium channel II and III alpha-isoform mRNAs in neurons and microglia after status epilepticus in the rat hippocampus.

Authors:  E Aronica; B Yankaya; D Troost; E A van Vliet; F H Lopes da Silva; J A Gorter
Journal:  Eur J Neurosci       Date:  2001-03       Impact factor: 3.386

6.  Carbamazepine, but not valproate, displays pharmacoresistance in lamotrigine-resistant amygdala kindled rats.

Authors:  Ajay K Srivastava; H Steve White
Journal:  Epilepsy Res       Date:  2012-11-14       Impact factor: 3.045

Review 7.  Kindling and status epilepticus models of epilepsy: rewiring the brain.

Authors:  Kiyoshi Morimoto; Margaret Fahnestock; Ronald J Racine
Journal:  Prog Neurobiol       Date:  2004-05       Impact factor: 11.685

8.  Molecular and functional changes in voltage-dependent Na(+) channels following pilocarpine-induced status epilepticus in rat dentate granule cells.

Authors:  R K Ellerkmann; S Remy; J Chen; D Sochivko; C E Elger; B W Urban; A Becker; H Beck
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

9.  Anticonvulsant pharmacology of voltage-gated Na+ channels in hippocampal neurons of control and chronically epileptic rats.

Authors:  Stefan Remy; Bernd W Urban; Christian E Elger; Heinz Beck
Journal:  Eur J Neurosci       Date:  2003-06       Impact factor: 3.386

10.  Lamotrigine and remacemide protect striatal neurons against in vitro ischemia: an electrophysiological study.

Authors:  P Calabresi; M Marti; B Picconi; E Saulle; C Costa; D Centonze; F Pisani; G Bernardi
Journal:  Exp Neurol       Date:  2003-08       Impact factor: 5.330

View more
  18 in total

Review 1.  Disease modification in epilepsy: from animal models to clinical applications.

Authors:  Melissa L Barker-Haliski; Dan Friedman; Jacqueline A French; H Steve White
Journal:  Drugs       Date:  2015-05       Impact factor: 9.546

2.  Development and pharmacologic characterization of the rat 6 Hz model of partial seizures.

Authors:  Cameron S Metcalf; Peter J West; Kyle E Thomson; Sharon F Edwards; Misty D Smith; H Steve White; Karen S Wilcox
Journal:  Epilepsia       Date:  2017-04-27       Impact factor: 5.864

3.  The Positive Allosteric Modulator of α2/3-Containing GABAA Receptors, KRM-II-81, Is Active in Pharmaco-Resistant Models of Epilepsy and Reduces Hyperexcitability after Traumatic Brain Injury.

Authors:  Jeffrey M Witkin; Guanguan Li; Lalit K Golani; Wenhui Xiong; Jodi L Smith; Xingjie Ping; Farjana Rashid; Rajwana Jahan; Rok Cerne; James M Cook; Xiaoming Jin
Journal:  J Pharmacol Exp Ther       Date:  2019-11-06       Impact factor: 4.030

4.  Evaluation of Cannabidiol in Animal Seizure Models by the Epilepsy Therapy Screening Program (ETSP).

Authors:  Brian D Klein; Catherine A Jacobson; Cameron S Metcalf; Misty D Smith; Karen S Wilcox; Aidan J Hampson; John H Kehne
Journal:  Neurochem Res       Date:  2017-05-06       Impact factor: 3.996

5.  Validation of a Preclinical Drug Screening Platform for Pharmacoresistant Epilepsy.

Authors:  Melissa L Barker-Haliski; Kristina Johnson; Peggy Billingsley; Jennifer Huff; Laura J Handy; Rizvana Khaleel; Zhenmei Lu; Matthew J Mau; Timothy H Pruess; Carlos Rueda; Gerald Saunders; Tristan K Underwood; Fabiola Vanegas; Misty D Smith; Peter J West; Karen S Wilcox
Journal:  Neurochem Res       Date:  2017-03-16       Impact factor: 3.996

6.  The Anticonvulsant Effects of Alpha-2 Adrenoceptor Agonist Dexmedetomidine on Pentylenetetrazole-Induced Seizures in Rats.

Authors:  Arzuhan Cetindag Ciltas; Ercan Ozdemir; Erkan Gumus; Ahmet Sevki Taskiran; Handan Gunes; Gokhan Arslan
Journal:  Neurochem Res       Date:  2021-09-07       Impact factor: 3.996

Review 7.  Drug Resistance in Epilepsy: Clinical Impact, Potential Mechanisms, and New Innovative Treatment Options.

Authors:  Wolfgang Löscher; Heidrun Potschka; Sanjay M Sisodiya; Annamaria Vezzani
Journal:  Pharmacol Rev       Date:  2020-07       Impact factor: 25.468

8.  Reducing versus stopping antiepileptic medications after temporal lobe surgery.

Authors:  Ruta Yardi; Anna Irwin; Husam Kayyali; Ajay Gupta; Dileep Nair; Jorge Gonzalez-Martinez; William Bingaman; Imad M Najm; Lara E Jehi
Journal:  Ann Clin Transl Neurol       Date:  2014-02-11       Impact factor: 4.511

Review 9.  Animal models of epilepsy: use and limitations.

Authors:  Ludmyla Kandratavicius; Priscila Alves Balista; Cleiton Lopes-Aguiar; Rafael Naime Ruggiero; Eduardo Henrique Umeoka; Norberto Garcia-Cairasco; Lezio Soares Bueno-Junior; Joao Pereira Leite
Journal:  Neuropsychiatr Dis Treat       Date:  2014-09-09       Impact factor: 2.570

10.  Efficacy of Retigabine on Acute Limbic Seizures in Adult Rats.

Authors:  L K Friedman; A M Slomko; J P Wongvravit; Z Naseer; S Hu; W Y Wan; S S Ali
Journal:  J Epilepsy Res       Date:  2015-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.